More than 67,000 cases of deodorant sold nationwide recalled

WASHINGTON — Tens of thousands of cases of Power Stick deodorant have been voluntarily recalled due to a manufacturing defect. 

A.P. Deauville, the Easton, Pennsylvania-based manufacturer of Power Stick deodorant, issued a recall on July 10 for 67,214 combined total cases of three different types of antiperspirant, according to an FDA enforcement report. 

The affected products include Power Stick for her roll-on Antiperspirant Deodorant Powder Fresh, Power Stick Invisible Protection Roll-On Antiperspirant Deodorant Spring Fresh and Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant Deodorant. 

All of the recalled deodorants were 1.8 oz size. 

The recalled products were distributed nationwide, according to the FDA report. The manufacturer’s website states that Power Stick has distribution in “most of the largest discount retailers” in the country. 

• Power Stick for her roll-on Antiperspirant Deodorant Powder Fresh, UPC Code 815195019313 NDC# 42913-038-00 – Lots  #032026B011, 032226B031, 051626C241, 061526C882, 071226D371, 071226D381, 082526E341, 082826E402
• Power Stick Invisible Protection Roll-On Antiperspirant Deodorant Spring Fresh, UPC Code 815195018194 NDC# 42913-039-00 – Lots #031726A991, 041226B561, 062026C901, 062026C911, 071026D351, 071026D361, 071326D391, 111626G231
• Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant Deodorant, UPC Code 815195018224 NDC# 42913-040-00 – Lots  #101225D781, 032926B281, 032826B221, 041126B531, 062226D011, 070626D301, 070626D333, 111026G051, 111326G091, 111626G221

The report cited deviations from CGMP, which refers to the Current Good Manufacturing Practice regulations enforced by the FDA. “CGMP provides for systems that assure proper design, monitoring, and control of manufacturing processes and facilities,” the FDA site explains. “Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations.”

The recall didn’t specify the particular defect with the deodorants.